RxDoctor Payments Data

Supakunya Edmonson, DO

Neurology · Norfolk, VANPI 1366420853

Payments from drug & device makers

$13,964in general payments, 2019–2025

Across 827 payments — averaging $16.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$1K
  • Novartis$1K
  • AbbVie$1K
  • Biogen$987
  • AstraZeneca$793
  • Sanofi$644
  • plus $8K from 54 others

What the payments were for

  • Speaking & faculty fees$640%
  • Food & beverage$13,76599%
  • Education$1341%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
UCB, Inc.89$1,480
Novartis97$1,250
AbbVie(2 entities)116$1,203
Biogen62$987
AstraZeneca(2 entities)40$793
Sanofi29$644
Biohaven Pharmaceuticals, Inc.20$550
Amgen27$526
Teva Pharmaceuticals USA, Inc.34$497
EMD Serono, Inc.35$445
Sunovion Pharmaceuticals Inc.20$420
Genentech USA, Inc.22$382
Biohaven Pharmaceutical Holding Company Ltd.13$358
Greenwich Biosciences, Inc.21$345
SK Life Science, Inc.12$342
Lundbeck LLC19$331
Amneal Pharmaceuticals LLC15$224
Mallinckrodt Hospital Products Inc.10$217
Lilly USA, LLC14$214
Insightec,inc2$214
Kyowa Kirin, Inc.10$183
Eisai Inc.10$174
CSL Behring8$159
Adamas Pharmaceuticals, Inc.3$155
Supernus Pharmaceuticals, Inc.9$148
Argenx US, Inc.3$136
Avanir Pharmaceuticals, Inc.6$132
Johnson & Johnson5$118
Neurelis, Inc.8$109
Banner Life Sciences, LLC5$109
Bristol Myers Squibb6$100
Upsher-smith Laboratories LLC4$96
MDD US Operations, LLC6$90
Grifols USA, LLC5$87
Acorda Therapeutics, Inc5$87
E.r. Squibb & Sons, L.L.C.4$73
GE HealthCare3$73
Collegium Pharmaceutical, Inc.3$57
Mallinckrodt Enterprises LLC3$39
Neurocrine Biosciences, Inc.2$37
Arbor Pharmaceuticals, Inc.2$30
Jazz Pharmaceuticals Inc.2$28
Acadia Pharmaceuticals Inc1$27
Ipsen Biopharmaceuticals, Inc1$24
Pfizer1$23
Promius Pharma LLC1$22
Corium, LLC1$22
Otsuka America Pharmaceutical, Inc.1$19
Aquestive Therapeutics, Inc.1$19
Impel Pharmaceuticals Inc.1$18
Akcea Therapeutics, Inc.1$18
Tanabe Pharma America, Inc.1$18
Zogenix Inc.1$18
Almatica Pharma LLC1$16
Bausch Health US, LLC1$14
Alnylam Pharmaceuticals Inc.1$14
Azurity Pharmaceuticals, Inc.1$14
Boston Scientific1$13
Assertio Therapeutics, Inc.1$12
Zyla Life Sciences, Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,964 in reported general payments places this provider in the 70th percentile of 474 neurology providers in Virginia.

See all neurology providers in Virginia

Medicare billing

Part B allowed, 2024
$31,386
Medicare patients
227
Services billed
307

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Norfolk

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →